Related Experiment Video
Updated: May 25, 2026

Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology
Published on: March 22, 2012
Galactomannan testing might be useful for early diagnosis of fusariosis
Małgorzata Mikulska1, Elisa Furfaro, Valerio Del Bono
1Division of Infectious Diseases, San Martino University Hospital, 16132 Genoa, Italy. m_mikulska@yahoo.com
Abstract:
Galactomannan (GM) is used to diagnose aspergillosis. We present a case of a hematopoietic stem cell transplantation recipient with fusariosis who received early antifungal treatment based on GM positivity. Additionally, 3 Fusarium isolates tested positive for GM. Fusarium is another mold containing GM. GM might be useful for diagnosing fusariosis in high-risk patients.
Insights
Galactomannan (GM) testing aided early antifungal treatment for a hematopoietic stem cell transplant patient with fusariosis. This indicates GM may help diagnose invasive Fusarium infections in high-risk individuals.
Area of Science:
- Mycology
- Infectious Diseases
- Transplantation Medicine
Background:
- Galactomannan (GM) is a biomarker primarily used for diagnosing invasive aspergillosis.
- Hematopoietic stem cell transplantation (HSCT) recipients are at high risk for invasive fungal infections.
- Fusarium species are emerging opportunistic molds that can cause severe infections in immunocompromised patients.
Observation:
- A case study involving an HSCT recipient diagnosed with fusariosis is presented.
- Early antifungal treatment was initiated based on positive GM test results.
- Laboratory testing revealed that three Fusarium isolates were also positive for GM.
Findings:
- The presence of GM in a Fusarium infection suggests that this biomarker may not be specific to Aspergillus.
- Fusarium species, like Aspergillus, can produce galactomannan.
- GM positivity correlated with invasive Fusarium infection in this HSCT patient.
Implications:
- Galactomannan testing could potentially be a valuable tool for the early diagnosis of fusariosis in high-risk patient populations.
- Expanding the diagnostic utility of GM testing may improve outcomes for patients with invasive mold infections.
- Further research is warranted to validate the role of GM in diagnosing fusariosis and other non-Aspergillus invasive fungal infections.

